For more information on our studies please click this link and fill out some information, and we will contact you! (Or call 1-888-819-0004).
CAE Effectiveness Study
Customized Adherence Enhancement (CAE) is a brief, practical Bipolar Disorder-specific approach that identifies individual patient adherence barriers and then targets these areas for intervention using a flexibly administered modular format.
iTAB-CV
A personalized patient-centered adherence intervention iTAB-CV + Self-Monitoring (iTAB-CV + SM) vs. Self-Monitoring (SM) alone in poorly adherent hypertensive persons with bipolar disorder. The observation duration will be 12 months. Click for more information.
TEAM 2
To find out if a group educational and behavioral intervention, called TargetEd MAnageMent Intervention (TEAM), helps African-American men with reducing their stroke risk factors. The TEAM approach is intended to reduce the unacceptably high rates of stroke and stroke complications in African-American (AA) men who have experienced mild deficit stroke or transient ischemic attack (TIA, mini-stroke). Click for more information.
SMART 2.0
In collaboration with the University of Iowa, SMART is a RCT for adults with sub-optimally controlled epilepsy. It is a virtually delivered educational and behavioral intervention intended to enhance epilepsy self-management in rural/sub rural populations. Click for more information.
SMART 3.0
Epilepsy self-management program delivered by a coalition of partners dedicated to supporting the multi-dimensional needs of individuals with epilepsy. SMART is delivered in collaboration with the Epilepsy Association of Western and Central PA, Epilepsy Association, and Epilepsy Alliance Ohio to increase the availability and accessibility of resources for people with epilepsy in Ohio, Pennsylvania, West Virginia, and Kentucky. Click for more information.
CADRC
The Cleveland Alzheimer’s Disease Research Center (CADRC) aims to study the different forms of dementia in the hope that learning more about the disease can lead to new forms of treating, and eventually curing, Alzheimer’s and related disorders. The CADRC will follow individuals over time collecting clinical information, specimens, and imaging data for future research. We not only will be enrolling individuals with memory problems, such as those diagnosed with Alzheimer’s disease or Lewy body dementia, but we also want to follow healthy individuals over time. Click for more information.